The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of Cytochrome c Oxidase and Adenosine Triphosphate Synthesis
Open accessAbstract
Advanced glycation end products (AGEs) are implicated in diabetic complications. However, their role in β-cell dysfunction is less clear. In this study we examined the effects of AGEs on islet function in mice and in isolated islets. AGE-BSA or BSA was administered ip to normal mice twice a day for 2 wk. We showed that AGE-BSA-treated mice exhibited significantly higher glucose levels and lower insulin levels in response to glucose challenge than did BSA-treated mice, although there were no significant differences in insulin sensitivity and islet morphology between two groups. Glucose-stimulated insulin secretion by islets of the AGE-BSA-treated mice or AGE-BSA-treated normal islets was significantly lower than that by islets isolated from the BSA-treated mice or BSA-treated normal islets. Furthermore, AGE treatment of islet β-cells inhibited ATP production, and glimepiride, a sulfonylurea derivative, restored glucose-stimulated insulin secretion. Further investigation indicated that AGEs inhibited cytochrome c oxidase activity by inducing the expression of inducible nitric oxide synthase (iNOS). Blocking the formation of nitric oxide with an iNOS selective inhibitor aminoguanidine reversed the inhibitory effects of AGEs on ATP production and insulin secretion. We conclude that AGEs inhibit cytochrome c oxidase and ATP production, leading to the impairment of glucose-stimulated insulin secretion through iNOS-dependent nitric oxide production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AGEs also contribute to pancreatic 𝛽-cell dysfunction, another key component in the pathogenesis of T2DM.”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [137]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,741
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Cleeter, M. W. J., Cooper, J. M., Darley-Usmar, V. M., Moncada, S., & Schapira, A. H. V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00424-2 · Cited by 1,241
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,113
Brown, G. C., & Cooper, C. E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01290-3 · Cited by 1,055
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,006
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Self-citationDiabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 723
Self-citationA Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm
Matschinsky, F. (1996) · Diabetes · doi:10.2337/diab.45.2.223 · Cited by 721
The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 710
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Self-citationLipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., & Vlassara, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6434 · Cited by 571
Self-citationUnger, R. H., & Grundy, S. M. (1985) · Diabetologia · doi:10.1007/bf00273856 · Cited by 452
Insulin resistance and pancreatic cell failure
Kasuga, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29189 · Cited by 433
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
Krauss, S., Zhang, C., Scorrano, L., Dalgaard, L. T., St‐Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19774 · Cited by 405
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
Krauss, S., Zhang, C.-Y., Scorrano, L., Dalgaard, L. T., St-Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319774 · Cited by 401
Identification of arginine as a precursor of endothelium-derived relaxing factor.
Sakuma, I., Stuehr, D. J., Gross, S. S., Nathan, C., & Levi, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.22.8664 · Cited by 399
Diabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 336
Self-citationbeta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
Porte, D., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s160 · Cited by 330
Eizirik, D. L., Korbutt, G. S., & Hellerström, C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115989 · Cited by 313
Hofmann, S. M., Dong, H. H., Li, Z., Cai, W., Altomonte, J., Thung, S. N., Zeng, F., Fisher, E. A. A., & Vlassara, H. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2082 · Cited by 296
Self-citationLeahy, J. L., Cooper, H. E., Deal, D. A., & Weir, G. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112389 · Cited by 289
Cai, W., Gao, Q.-D., Zhu, L., Peppa, Μ., He, C., & Vlassara, H. (2002) · Molecular Medicine · doi:10.1007/bf03402014 · Cited by 236
Self-citationCorbett, J. A., & McDaniel, M. L. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.2.559 · Cited by 234
Ignarro, L. J. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00772.x · Cited by 229
Insulin Resistance and Type 2 Diabetes in High-Fat–Fed Mice Are Linked to High Glycotoxin Intake
Sandu, O. A., Song, K., Cai, W., Zheng, F., Uribarri, J., & Vlassara, H. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2314 · Cited by 214
Self-citationPrevention of diabetic nephropathy in mice by a diet low in glycoxidation products
Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M. W., & Vlassara, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.283 · Cited by 207
Self-citationCooper, C. E., & Giulivi, C. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00310.2006 · Cited by 176
Patanè, G., Anello, M., Piro, S., Vigneri, R., Purrello, F., & Rabuazzo, A. M. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2749 · Cited by 172
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
Lin, R.-Y., Choudhury, R. P., Cai, W., Lu, M. M., Fallon, J. T., Fisher, E. A. A., & Vlassara, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00050-9 · Cited by 169
Self-citationMarshak, S., Leibowitz, G., Bertuzzi, F., SOCCI, C., Kaiser, Ν., Gross, D. J., Cerasi, E., & Melloul, D. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1230 · Cited by 167
Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice
Peppa, M., Brem, H., Ehrlich, P., Zhang, J.-G., Cai, W., Li, Z., Croitoru, A., Thung, S., & Vlassara, H. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2805 · Cited by 153
Corbett, J. A., Wang, J., Hughes, J. H., Wolf, B. A., Sweetland, M. A., Lancaster, J. R., & McDaniel, M. L. (1992) · Biochemical Journal · doi:10.1042/bj2870229 · Cited by 141
Chen, Y., Yan, S. S., Colgan, J. D., Zhang, H.-P., Luban, J., Schmidt, A. M., Stern, D. M., & Herold, K. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1399 · Cited by 130
Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice
Peppa, Μ., He, C., Hattori, M., McEvoy, R. C., Zheng, F., & Vlassara, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1441 · Cited by 129
Self-citationSeleznev, K., Zhao, C., Zhang, X. H., Song, K., & Ma, Z. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604330200 · Cited by 125
Self-citationNitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology
Giulivi, C., Kato, K., & Cooper, C. E. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00307.2006 · Cited by 122
Historical Perspective of the Maillard Reaction in Food Science
Finot, P. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.001 · Cited by 121
Tajiri, Y., Möller, C., & Grill, V. (1997) · Endocrinology · doi:10.1210/endo.138.1.4851 · Cited by 109
Lin, R.-Y., Reis, E. D., Dore, A. T., Lu, M., Ghodsi, N., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00008-4 · Cited by 109
Self-citationGlycoxidation and Diabetic Complications: Modern Lessons and a Warning?
Vlassara, H., & Uribarri, J. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000032406.84813.f6 · Cited by 105
Self-citationMitsuhashi, T., Vlassara, H., Founds, H., & Li, Y. M. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00110-5 · Cited by 90
Self-citationAmore, A., Cirina, P., Mitola, S. M. F., Peruzzi, L., Gianoglio, B., Rabbone, I., Sacchetti, C., Cerutti, F., Grillo, C., & Coppo, R. (1997) · Kidney International · doi:10.1038/ki.1997.4 · Cited by 82
Lim, M., Park, L., Shin, G., Hong, H., Kang, I., & Park, Y. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.011 · Cited by 81
Kaiser, N., CORCOS, A. P., Sarel, I., & Cerasi, E. (1991) · Endocrinology · doi:10.1210/endo-129-4-2067 · Cited by 76
Song, K., Zhang, X. H., Zhao, C., Ang, N. T., & Ma, Z. A. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0169 · Cited by 56
Self-citationCorbett, J. A., & McDaniel, M. L. (1996) · Methods · doi:10.1006/meth.1996.0074 · Cited by 54
Sumi, D., & Ignarro, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1841 · Cited by 54
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model
Šebeková, K., Faist, V., Hofmann, T. F., Schinzel, R., & Heidland, A. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50084 · Cited by 51
Advanced glycosylation end products induce NF-κB dependent iNOS expression in RAW 264.7 cells
Wu, C., Huang, C.-M., Lin, C., Ho, Y.-S., Chen, C., & Lee, H.-M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00212-5 · Cited by 40
Armando Rojas, R., Caveda, L., Romay, C., López, E., Valdés, S., Padrón, J. R., Glaría, L., Martínez-Estrada, O. M., & Delgado, R. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1180 · Cited by 35
Piercy, V., Toseland, C. D. N., & Turner, N. C. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90073-7 · Cited by 27
Aminoguanidine Exerts a β‐Cell Function‐preserving Effect in High Glucose‐cultured β‐Cells (INS‐1)
Tajiri, Y., & Grill, V. (2000) · Journal of Diabetes Research · doi:10.1155/edr.2000.111 · Cited by 19
Cited by
Sorted by citations
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 706
Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
Vlassara, H., & Uribarri, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0453-1 · Cited by 594
Self-citationFinch, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909606106 · Cited by 417
Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 402
Self-citation
Metadata
- Authors
- Zhao, Z., Zhao, C., Zhang, X. H., Zheng, F., Cai, W., Vlassara, H., & Ma, Z. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Zhao, Zhengshan
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-02-26
- Volume
- 150
- Issue
- 6
- Pages
- 2569-2576
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC2689792
- OpenAlex
- W2081193499
- Cited by
- 132
- References
- 54
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 11 · 2015: 6 · 2014: 13 · 2013: 17 · 2012: 12
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063076, R21DK074805, DK074805, DK063076)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- advanced glycation end products, glucose-stimulated insulin secretion, beta-cell dysfunction, cytochrome c oxidase, nitric oxide, inducible nitric oxide synthase, ATP production, islet function, diabetes complications, aminoguanidine, sulfonylureas, AGE-BSA
- MeSH terms
- Insulin Secretion, Adenosine Triphosphate, Animals, Cells, Cultured, Electron Transport Complex IV, Diabetes Mellitus, Disease Models, Animal, Female, Glucose, Insulin, Male, Mice, Inbred C57BL, Nitric Oxide, Glycation End Products, Advanced, Insulin-Secreting Cells, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
